SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016035
Filing Date
2022-08-09
Accepted
2022-08-09 16:06:55
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20220630.htm   iXBRL 10-Q 2591173
2 EX-10.2 rphm-ex10_2.htm EX-10.2 21485
3 EX-31.1 rphm-ex31_1.htm EX-31.1 20117
4 EX-31.2 rphm-ex31_2.htm EX-31.2 19843
5 EX-32.1 rphm-ex32_1.htm EX-32.1 13322
6 EX-32.2 rphm-ex32_2.htm EX-32.2 13744
7 GRAPHIC img1365250_0.jpg GRAPHIC 19896
8 GRAPHIC img1365250_1.jpg GRAPHIC 289599
9 GRAPHIC img26604459_0.jpg GRAPHIC 11204
  Complete submission text file 0000950170-22-016035.txt   7797139

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rphm-20220630_lab.xml EX-101.LAB 340523
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rphm-20220630_cal.xml EX-101.CAL 32982
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rphm-20220630_def.xml EX-101.DEF 183238
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rphm-20220630.xsd EX-101.SCH 40432
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rphm-20220630_pre.xml EX-101.PRE 284594
57 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20220630_htm.xml XML 1089641
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 221148272
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences